Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02952014 · ClinicalTrials.gov registry record · NA

Assessment of a Pre-Workout Dietary Supplement

A NA study, sponsored by Texas A&M University.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT02952014: Completed NA study, sponsored by Texas A&M University.

NCT02952014 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02952014, a NA study, has completed, sponsored by Texas A&M University.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

The purpose of this study is to examine the acute effects of a pre-workout dietary supplement on energy metabolism, cardiovascular hemodynamics, blood metabolites and mental focus.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT C4 Extreme
  • DIETARY_SUPPLEMENT C4 Extreme (without Advantra Z

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2014-02
Est. Completion 2014-05
Phase NA
Texas A&M University

95 total trials

What the finished NCT02952014 record still lists

NCT02952014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT02952014 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02952014 about?

NCT02952014 is a clinical study titled "Assessment of a Pre-Workout Dietary Supplement". The purpose of this study is to examine the acute effects of a pre-workout dietary supplement on energy metabolism, cardiovascular hemodynamics, blood metabolites and mental focus.

What is the current status of trial NCT02952014?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2014-02. Estimated completion is 2014-05.

What interventions are being tested in trial NCT02952014?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), C4 Extreme (DIETARY_SUPPLEMENT), C4 Extreme (without Advantra Z (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02952014?

This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02952014's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02952014, the US trial registry maintained by the National Library of Medicine. NCT02952014 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.